Callahan Advisors, LLC Abb Vie Inc. Transaction History

Callahan Advisors, LLC

$929 Million
Q2 2024

A detailed history of Callahan Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Callahan Advisors, LLC holds 4,708 shares of ABBV stock, worth $927,287. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,708

Previous 4,703 0.11%

Holding current value

$927,287

Previous $856,000 5.72%

% of portfolio

0.09%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $773 - $903	5 Added 0.11%	4,708 $807,000
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $639 - $728	4 Added 0.09%	4,703 $856,000
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $825 - $929	6 Added 0.13%	4,699 $728,000
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $300,978 - $348,426	-2,253 Reduced 32.44%	4,693 $699,000
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $3.63 Million - $4.51 Million	-27,362 Reduced 79.75%	6,946 $935,000
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $26,970 - $32,344	-195 Reduced 0.57%	34,308 $5.55 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $9,931 - $11,390	-74 Reduced 0.21%	34,503 $4.63 Million
Q2 2022 Jul 29, 2022	BUY	$137.62 - $174.96 $52,983 - $67,359	385 Added 1.13%	34,577 $5.3 Million
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $15,177 - $18,831	115 Added 0.34%	34,192 $5.54 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $322 - $407	-3 Reduced 0.01%	34,077 $4.61 Million
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $15,108 - $17,150	-142 Reduced 0.41%	34,080 $3.68 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $5,260 - $5,860	50 Added 0.15%	34,222 $3.86 Million
Q1 2021 Apr 21, 2021	BUY	$102.3 - $112.62 $10,230 - $11,262	100 Added 0.29%	34,172 $3.7 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $5,553 - $7,498	-69 Reduced 0.2%	34,072 $3.65 Million
Q3 2020 Oct 26, 2020	BUY	$85.91 - $100.83 $85,910 - $100,830	1,000 Added 3.02%	34,141 $2.99 Million
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $796,357 - $1.07 Million	10,854 Added 48.7%	33,141 $3.25 Million
Q1 2020 Apr 06, 2020	SELL	$64.5 - $97.79 $1,612 - $2,444	-25 Reduced 0.11%	22,287 $1.7 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $2,452 - $3,068	34 Added 0.15%	22,312 $1.98 Million
Q3 2019 Oct 21, 2019	BUY	$62.98 - $75.72 $69,278 - $83,292	1,100 Added 5.19%	22,278 $1.69 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $663,570 - $848,198	10,100 Added 91.17%	21,178 $1.54 Million
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $57,855 - $68,092	-750 Reduced 6.34%	11,078 $893,000
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $15,914 - $17,692	179 Added 1.54%	11,828 $1.12 Million
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $31,346 - $34,373	350 Added 3.1%	11,649 $1.13 Million
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $789,235 - $1.01 Million	11,299	11,299 $1 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Callahan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callahan Advisors, LLC with notifications on news.

Account

Callahan Advisors, LLC Abb Vie Inc. Transaction History